Navigate Up
Sign In
Launch the Developer Dashboard
Skip navigation links
News and Announcements
By-laws
Commissioners
Links
Standards and Guidelines
Self-Study Guidelines
Training Programs
ComACC Home

The Methodist Hospital/Weill Cornell Medical College

Director: Address:

Ping Wang, PhD, DABCC, FACB
Telephone: 713-441-3294
Fax: 713-441-1565
E-mail: pwang@tmhs.org

Department of Pathology and Genomic
Medicine
The Methodist Hospital
6565 Fannin Street
MS 205
Houston, TX 77030

Faculty and Research Interests

The Methodist Hospital/Weill Cornell Medical College

Ping Wang, PhD, DABCC, FACB

Chemistry, toxicology, TDM, Pharmacogenomics, molecular diagnostics

David Bernard, MD, PhD

Chemistry, hematology, informatics, management

Wayne Chandler, MD

Chemistry, coagulation, automation, management

Geoffrey Land, PhD

HLA, Immunology

Smaroula Dilioglou, PhD

HLA, Immunology

Youli Zu, MD, PhD

Hematopathology

Randy Olsen, MD, PhD

Microbiology, molecular diagnostics

Beverly C Handy, MD

Clinical chemistry (MD Anderson Cancer Center)

 

Program Listing:

Level(s) of training:
Number of Positions available per year:
Duration of program:
Approximate annual salary or stipend:
Source of funding:
Current number of trainees:
Number of past graduates:
Date of ComACC accreditation:

Postdoctoral
1 every two years
2 years
Commensurate with level of post-graduate training
Departmental/Research Grants
1
N/A
November 2011

Application Procedure:

Prerequisites:

 

Doctoral degrees (PhD, MD, or PharmD and equivalent) at accredited institutions are required for admission into the program. Individuals with doctoral degrees in the following and other relevant life science areas are encouraged to apply: Clinical Chemistry, Chemistry, Biochemistry, Medicine, Molecular Biology, Toxicology, Pharmacology, Physiology, Genetics. Candidates should have met 30-hour minimum requirement of undergraduate and/or graduate level biochemistry or chemistry courses, which is required for ABCC certification. Previous experience in clinical chemistry is not required but strong interests in laboratory medicine and research is required.

Procedures:

Interested applicants should first submit a letter of interest to the program director. On confirmation of training position vacancy, applicants should submit curriculum vitae, copies of credentials, undergraduate and graduate transcripts, and three letters of reference to the program director. In addition, the applicants will need to complete an application form for the specific position on Methodist website. Applicants with education obtained at institutions outside the U.S. or Canada must, at their expense, have their credentials evaluated by acceptable agencies.

Deadline

January 15th of the year of the intended fellowship which begins July 1st


Program Description
:

One two-year fellowship slot is available every two academic years. The first year of the program is an introduction to and rotation through the various laboratories providing clinical services to the hospital and outpatient center. These laboratories include the core laboratory, diagnostic immunology, point-of-care testing, and satellite laboratories. Elective rotations in selected laboratory areas of interest will also be provided. Major equipment in these laboratories includes several Ortho Fusion dry chemistry systems, several Siemens Centaurs, a Waters LC tandem mass spectrometer, and an Abbott Architect. The fellow will study proper testing procedures (specimen collection and processing), methodology, and clinical correlation of testing. Small research projects including, but not limited to, method development and clinical case study will also be assigned.

The second year will focus on management, on-call duty, and self-initiated research approved by the program director. During this time, the fellow will gradually assume greater responsibilities in the clinical service labora-tories. The fellow will review and address laboratory management and patient care problems. The fellow is ex-pected to obtain board certification in clinical chemistry by the American Board of Clinical Chemistry (ABCC) by the end of the fellowship.